According to Ajanta Pharma latest financial reports the cash on hand of AJANTPHARM is $100.05M, an increase of 155.96% to 2022. At the end of 2022 company had $39.09M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $100.05M | 155.96% |
2022 | $39.09M | -13.21% |
2021 | $45.04M | 40.33% |
2020 | $32.09M | 68.54% |
2019 | $19.04M | - |